Navigation Links
Navneet Tyagi Supports Continued Efforts for Alzheimer Detection Procedures
Date:6/20/2013

New York, New York (PRWEB) June 20, 2013

As a key researcher in the areas of protein folding and misfolding, Navneet Tyagi has remained closely linked to neurodegenerative diseases, including ALS and Alzheimer’s disease. Throughout the myriad of scientific research that Tyagi has participated in, he has held steady to his commitment of identifying early onset of these severe and mysterious neurological conditions. It is his hope that through early diagnosis, more medical researchers will be able to understand about the nature of conditions, such as Alzheimer’s, and potentially discover new avenues for progressive treatment or even a cure.

For this reason, Navneet Tyagi commends new developments of Alzheimer’s diagnostic procedures highlighted in a recent MSN article. The article focuses on an eye test that has been used in clinical setting to detect the presence of Alzheimer’s disease in patients. MSN explains, “A new study will trial an American-developed NeuroVision test aimed at detecting people at risk of developing Alzheimer's disease. Dr. Lance Macaulay from CSIRO said recent research showed Alzheimer's disease developed slowly.” According to Macaulay, up until recently it has only been understood that detection of Alzheimer’s disease is only possible when the condition has reached later stages in patients.

Fortunately, new advancements in eye scanning tests could help provide earlier detection of this condition. MSN reports, “…with a positron emission tomography (PET) scan, plaque build-up in the brain could be detected 17 years before symptoms appeared.” Even more importantly, if successful, the PET scan could be implemented as a non-invasive and affordable test to help identify those who may be developing Alzheimer’s disease. For Navneet Tyagi, earlier research opens up new opportunities for attempting new treatments.

“Since Alzheimer’s disease diagnoses usually come much later—once the condition has progressed—available treatments and their results are really hard to track and study, especially in terms of offering recovery or a cure to patients. With earlier detection, researchers may be able to implement new solutions and studies to see if there is a way to attack this neurodegenerative disease during its earlier phases.”

According to MSN, there are trials of how the PET scan may be used for diagnosing Alzheimer’s disease in patients. “It is very encouraging to see that medical researchers are thinking outside of the box to determine ways to understand the body as a whole and use different resources to determine the presence of other potential problems. For instance, doctors being able to detect neurological issues through a patient’s eye health. If this test does prove accurate, think of how many people could become aware of their Alzheimer’s development with a simple eye test, and thus, be able to receive treatment earlier on—it could even save their lives one day,” Navneet Tyagi concludes.

About:

Navneet Tyagi is a scientist and researcher who has worked extensively in the areas of protein folding and misfolding, and the roles of different molecular chaperones in neurodegenerative diseases like ALS, Parkinson’s, and Alzheimer’s. He also worked on the identification of early childhood onset neurodegenerative diseases. His previous findings on the sodium/D-glucose cotransporter protein have proven highly influential in the ongoing development of diabetes treatments. Tyagi was educated in India and received his PhD in Germany.

Read the full story at http://www.prweb.com/releases/2013/6/prweb10851153.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Study Supports Value of Sigmoidoscopy, an Alternative to Colonoscopy
2. Study supports urate protection against Parkinsons disease, hints at novel mechanism
3. Dietary fiber alters gut bacteria, supports gastrointestinal health
4. Narconon Louisiana Supports United Nations International Day Against Drug Abuse and Illicit Trafficking
5. NIDA supports development of combined anti-heroin and HIV vaccine
6. Little evidence supports autism treatment options in adolescents
7. $1.8 million grant supports investigation of psoriasis link to cardiovascular disease
8. John Templeton Foundation grant supports Princeton neuroscientists to study cognitive control
9. Human umbilical cord blood cell co-culture supports embryonic stem cell expansion
10. Study Supports Link Between Obesity, Cavities in Homeless Kids
11. Best Christmas Gift for 2012: Instant Stress Relief on CD! Relaxintuit.com’s Award-Winning Meditation CD Soothes Anxiety, Depression, Pain & Supports Deep, Healthy Sleep
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... Patients who would like ... in a fraction of the time as traditional braces – Wilckodontics®. Dr. Victoria ... now offers this revolutionary treatment with or without a referral. , Wilckodontics ...
(Date:4/25/2017)... ... , ... Back Pain Centers of America (BPC), which connects people ... their area, announces the launch of a new and proprietary customer relationship management (CRM) ... reputable physicians to help them with back or neck pain and helps to match ...
(Date:4/25/2017)... ... April 25, 2017 , ... Somnoware, a ... its patient care management module. Using this new feature, sleep physicians can now ... initiated on continuous positive airway pressure (CPAP), oral, or other forms of sleep ...
(Date:4/25/2017)... ... April 25, 2017 , ... Vetoquinol USA® , a ... UCII, part of the EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event ... the immunologic level. , The scientifically-developed Flexadin UCII supports the body’s normal repair ...
(Date:4/24/2017)... FLORIDA (PRWEB) , ... April 24, 2017 , ... ... telehealth technology yesterday, featuring Bring Your Own Device (BYOD) capabilities at Telehealth 2.0, ... LG CNS’ pre-packaged telehealth bundles, which pairs medical devices with a pre-programmed tablet ...
Breaking Medicine News(10 mins):
(Date:4/18/2017)... 18, 2017 Cogentix Medical, Inc. (NASDAQ: CGNT), ... Urology, Uro/Gyn and Gynecology markets with innovative and proprietary ... ended March 31, 2017 after the market close on ... will host a conference call and webcast to discuss ... 2, 2017 at 4:30 p.m. Eastern Time (3:30 p.m. ...
(Date:4/18/2017)... , April 18, 2017 Research and ... Market 2017-2021" report to their offering. ... The global arthroscopy devices market to grow at a ... report, Global Arthroscopy Devices Market 2017-2021, has been prepared based on ... covers the market landscape and its growth prospects over the coming ...
(Date:4/18/2017)... and BLOOMINGTON, Minn. , April ... IMMY ) ("Imprimis"), an ophthalmology-focused pharmaceutical company, ... Lens"), today announced the signing of a three-year ... Lens will deploy a dedicated sales team to ... the U.S., primarily focused in 13 states in ...
Breaking Medicine Technology: